Searched for
EBOLA TREATMENT TRIAL
More than 500 dead in DR Congo Ebola outbreakThe Ebola outbreak in the Democratic Republic of Congo has now claimed over 500 lives. World Health Organization figures show 1,561 confirm...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...
- Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
- US warns nationals to reconsider travel to Marburg-hit RwandaThe US has advised citizens to reconsider travel to Rwanda due to a Marburg virus outbreak that has killed 12, mostly health workers, since...
- Tocilizumab also found to be ineffective in coronavirus treatment, finds studyIndia’s clinical management protocol for Covid-19 advises the use of tocilizumab for treatment of patients who are in the severe stage of C...
- Cipla and Hetero seek clinical trial waiver for RemdesivirWhile all new drugs must undergo trials before getting marketing approval in India, the regulator can grant exemptions in public interest a...
- Delhi to use plasma technique for covid treatment on trial basisOn April 13, the Indian Council of Medical Research (ICMR) had sought participation of researchers for conducting clinical trial of convale...
- ICMR may use remdesivir if local companies can manufacture itThe Indian Council of Medical Research (ICMR) said it will consider using remdesivir, an experimental drug made by Gilead Sciences, to trea...
- Gilead’s drug leads global race to find virus treatmentThe update on the trials’ progress came a day after the World Health Organization said that remdesivir may be the only effective treatment ...
- Novel coronavirus: The hunt for a virus killerSome vaccine candidates for China virus are already at trial stage. But path to pharmacy is strewn with hurdles.
- Single human antibody shows promise against EbolaA single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protects monkeys from the lethal virus.
- Developing vaccine for Zika to take time: Johnson & Johnson's Paul StoffelsThe Zika virus, which was declared a global threat by the World Health Organisation last week, has been rapidly spreading in South America ...
- Ebola: Profile of a prolific killerThe worst outbreak of Ebola started in December 2013 in southern Guinea before spreading to two neighbouring west African countries.
- New antibody weapons against Marburg virus foundThe new antibodies identify and neutralise Marburg virus which has a mortality rate of up to 90 per cent.
- 53 drugs that may block Ebola identifiedA study found that among the better known drug types shown to hinder infection by an Ebola virus model are several cancer drugs, antihistam...
- Why we still don't have an Ebola vaccineAmid emergency WHO meetings and frenzied containment efforts, where is the Ebola vaccine?
- Vaccine against Ebola will not be available before 2015: WHOWHO declares effective Ebola vaccine will not be available before 2015;British pharma giant GlaxoSmithKline to start clinical trials of vac...
Load More
